Steven Perrin, President at Eledon Pharmaceuticals, Inc. (ELDN), bought 1,000 shares at $2.60 ($3K) on 2022-11-23, disclosed to the SEC on 2022-11-23.
Open-market purchase of $3k ELDN by President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.